Contraindication for IR-MPH use
Current stimulant treatment
Evidence of a clinically significant neurological disease that might affect cognition (e.g., delirium, dementia, epilepsy, head trauma, and multiple sclerosis)
Current or past history of psychosis
Estimated intelligence quotient score lower than 70

NCT02951754_exc_T1
Condition
Contraindication
NCT02951754_exc_T2
Drug
IR-MPH
NCT02951754_exc_T3
Temporal
Current
NCT02951754_exc_T4
Procedure
stimulant treatment
NCT02951754_exc_T5
Mood
Evidence
NCT02951754_exc_T6
Qualifier
clinically significant
NCT02951754_exc_T7
Condition
neurological disease
NCT02951754_exc_T8
Qualifier
might affect cognition
NCT02951754_exc_T9
Condition
delirium
NCT02951754_exc_T10
Condition
dementia
NCT02951754_exc_T11
Condition
epilepsy
NCT02951754_exc_T12
Condition
head trauma
NCT02951754_exc_T13
Condition
multiple sclerosis
NCT02951754_exc_T14
Scope
delirium, dementia, epilepsy, head trauma, and multiple sclerosis
NCT02951754_exc_T15
Scope
clinically significant neurological disease that might affect cognition
NCT02951754_exc_T16
Temporal
Current
NCT02951754_exc_T17
Temporal
past
NCT02951754_exc_T18
Observation
history
NCT02951754_exc_T19
Condition
psychosis
NCT02951754_exc_T20
Scope
Current or past
NCT02951754_exc_T21
Measurement
Estimated intelligence quotient score
NCT02951754_exc_T22
Value
lower than 70